Clinical Trial Update: Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults [Phase 3]

View source ↗

Summary

Phase 3 trial comparing E/C/F/TAF versus E/C/F/TDF in ART-naive adults with HIV-1; study completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• E/C/F/TAF (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide)
• E/C/F/TDF (emtricitabine/tenofovir disoproxil fumarate/cobicistat/elvitegravir)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV, HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2016-01-08